Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,652 | -1,005 | -812 | -294 | -1,934 |
| Depreciation Amortization | 4 | N/A | N/A | N/A | N/A |
| Accounts receivable | N/A | N/A | -2 | N/A | N/A |
| Accounts payable and accrued liabilities | 81 | N/A | N/A | N/A | N/A |
| Other Working Capital | 76 | -11 | -19 | 15 | 24 |
| Other Operating Activity | 624 | 492 | 411 | 166 | 1,371 |
| Operating Cash Flow | $-868 | $-525 | $-422 | $-113 | $-539 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | N/A | N/A | N/A | N/A |
| Net Acquisitions | -619 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-623 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 82 | 36 | 33 | N/A | 39 |
| Debt Issued | 245 | 233 | 162 | N/A | 395 |
| Common Stock Issued | 237 | 237 | 237 | 118 | 153 |
| Other Financing Activity | 835 | 0 | 0 | 0 | 63 |
| Financing Cash Flow | $1,399 | $506 | $432 | $118 | $651 |
| Exchange Rate Effect | N/A | 1 | 4 | N/A | N/A |
| Beginning Cash Position | 143 | 143 | 143 | 143 | 31 |
| End Cash Position | 51 | 125 | 157 | 149 | 143 |
| Net Cash Flow | $-93 | $-18 | $9 | $5 | $112 |
| Free Cash Flow | |||||
| Operating Cash Flow | -868 | -525 | -422 | -113 | -539 |
| Capital Expenditure | -5 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -872 | -525 | -422 | -113 | -539 |